We thank Drs Hatipoğlu and Wang for their interest in our article in this issue of CHEST1 on the association between hospital readmission and pulmonologist follow-up visits of patients with COPD. We agree that the question about how to reduce readmissions from any cause in patients with COPD is important, and it is still open for future studies. In our research, we did not define it as our main objective. We intentionally chose rehospitalization related to COPD exacerbation as an end point. We did not anticipate that a follow-up visit with a pulmonologist, who focused on the respiratory condition and on tailoring the right treatment of the patient’s respiratory illness, would reduce all readmission causes. We see a great significance in preventing some of the readmissions of patients with COPD, even for just a portion of that group.